Drug delivery systems (Record no. 15493)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 03427nam a2200337Ia 4500 |
001 - CONTROL NUMBER | |
control field | CRC0KE10294PDF |
003 - CONTROL NUMBER IDENTIFIER | |
control field | FlBoTFG |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20171224123653.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION | |
fixed length control field | m|||||o||d|||||||| |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr|||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 110525s2011 fluad sb 001 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781439806197 (ebook : PDF) |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | FlBoTFG |
Transcribing agency | FlBoTFG |
090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (OCLC) | |
Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) | RS199.5 |
Local cutter number (OCLC) ; Book number/undivided call number, CALL (RLIN) | .R36 2011 |
092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) | |
Classification number | 615.6 |
Item number | R185 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Ranade, Vasant V. |
245 10 - TITLE STATEMENT | |
Title | Drug delivery systems |
Medium | [electronic resource] / |
Statement of responsibility, etc | Vasant V. Ranade, John B. Cannon. |
250 ## - EDITION STATEMENT | |
Edition statement | 3rd ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc | Boca Raton : |
Name of publisher, distributor, etc | CRC Press, |
Date of publication, distribution, etc | 2011. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | xviii, 590 p. : |
Other physical details | ill. |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | ch. 1. Site-specific drug delivery using liposomes and emulsions as carriers -- ch. 2. Site-specific drug delivery utilizing monoclonal antibodies -- ch. 3. Role of polymers in drug delivery -- ch. 4. Implants in drug delivery -- ch. 5. Oral drug delivery -- ch. 6. Transdermal drug delivery -- ch. 7. Transmucosal and ocular drug delivery -- ch. 8. Miscellaneous forms of drug delivery -- ch. 9. Nanoscience and nanotechnology for drug delivery -- ch. 10. Regulatory considerations for drug delivery systems -- ch. 11. Drug delivery industry and the global outlook. |
520 ## - SUMMARY, ETC. | |
Summary, etc | "Drug delivery technologies represent a vast and vital area of research and development in pharmaceutics. The demand for innovative drug delivery systems continues to grow, and this growth drives a variety of new developments. Building on the foundation provided by the second edition, Drug Delivery Systems, Third Edition covers the latest in research, development, and regulations in industry and academia.The third edition of this popular book provides a comprehensive review of the latest research and development on drug delivery systems (including liposomal, transmucosal, transdermal, oral, polymeric, and monoclonal antibody directed delivery); it also contains a new chapter on nanoscience and technology for drug delivery along with cutting-edge business intelligence and strategies. These topics are spread into five sections: Site-specific drug delivery Polymers and implantable drug delivery systems Oral drug delivery Transdermal, transmucosal, ocular, and miscellaneous drug delivery systems Regulatory considerations and global outlook Written in a straightforward, clear, and concise manner, the authors provide a global perspective on current and future advances and market opportunities. The book answers the need for comprehensive information in a single resource for anyone venturing into this area of drug development and who desires an overview of the field, with extensive guidance on where to gain more information. Each chapter provides a table of marketed and investigational products, with numerous practical examples; the book also provides readers with a multitude of possible drug delivery systems that can be used to improve therapeutics, along with global and regulatory perspectives"--Provided by publisher. |
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE | |
Additional physical form available note | Also available in print edition. |
538 ## - SYSTEM DETAILS NOTE | |
System details note | Mode of access: World Wide Web. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drug delivery systems. |
655 #7 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
Source of term | lcsh |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cannon, John B. |
776 1# - ADDITIONAL PHYSICAL FORM ENTRY | |
International Standard Book Number | 9781439806180 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="http://marc.crcnetbase.com/isbn/9781439806197">http://marc.crcnetbase.com/isbn/9781439806197</a> |
Electronic format type | application/PDF |
Public note | Distributed by publisher. Purchase or institutional license may be required for access. |
No items available.